[go: up one dir, main page]

TR200900881A2 - Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler - Google Patents

Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler

Info

Publication number
TR200900881A2
TR200900881A2 TR2009/00881A TR200900881A TR200900881A2 TR 200900881 A2 TR200900881 A2 TR 200900881A2 TR 2009/00881 A TR2009/00881 A TR 2009/00881A TR 200900881 A TR200900881 A TR 200900881A TR 200900881 A2 TR200900881 A2 TR 200900881A2
Authority
TR
Turkey
Prior art keywords
odor
pharmaceutical compositions
taste
masked
stable pharmaceutical
Prior art date
Application number
TR2009/00881A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/00881A priority Critical patent/TR200900881A2/tr
Priority to PCT/TR2010/000023 priority patent/WO2010090612A1/en
Priority to EP10707989.9A priority patent/EP2393516B1/en
Publication of TR200900881A2 publication Critical patent/TR200900881A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, hoş olmayan tadı ve kokusu maskelenmiş, stabil farmasötik bileşimlere ve tıbbi kullanımlarına ilişkindir.
TR2009/00881A 2009-02-05 2009-02-05 Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler TR200900881A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/00881A TR200900881A2 (tr) 2009-02-05 2009-02-05 Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
PCT/TR2010/000023 WO2010090612A1 (en) 2009-02-05 2010-02-02 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
EP10707989.9A EP2393516B1 (en) 2009-02-05 2010-02-02 Stable, taste and odor masked pharmaceutical compositions comprising n-acetylcysteine and vitamin c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/00881A TR200900881A2 (tr) 2009-02-05 2009-02-05 Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler

Publications (1)

Publication Number Publication Date
TR200900881A2 true TR200900881A2 (tr) 2010-08-23

Family

ID=42122911

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/00881A TR200900881A2 (tr) 2009-02-05 2009-02-05 Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler

Country Status (3)

Country Link
EP (1) EP2393516B1 (tr)
TR (1) TR200900881A2 (tr)
WO (1) WO2010090612A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
EP2574333B1 (en) * 2011-09-27 2017-01-11 Friulchem SpA N-acetylcysteine effervescent tablet and its therapeutical applications
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine
CN111141855B (zh) * 2020-01-17 2022-05-17 南京嘉晨医药科技有限公司 一种对乙酰半胱氨酸口服溶液中甜蜜素的检测方法
CN114886860B (zh) * 2022-06-28 2023-04-25 山东达因海洋生物制药股份有限公司 一种乙酰半胱氨酸药物组合物及其制剂和制备工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184505A (en) 1962-06-18 1965-05-18 Mead Johnson & Co Process for the n-monoacylation of cysteine
JPS5270014A (en) * 1975-12-05 1977-06-10 Senju Pharma Co Stabilization of pyrido*3*22a*phenoxadine compounds
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
IT1217445B (it) 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (tr) 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
CH677606A5 (tr) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
ES2077757T5 (es) 1990-10-19 2001-06-01 Spirig Ag Pharmazeutische Prap Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
DE4103360A1 (de) * 1991-02-05 1992-08-06 Koehler Peter Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
WO1993000886A1 (de) * 1991-07-01 1993-01-21 Gerhard Gergely Reaktionsdotierte brausesysteme
ZA937353B (en) * 1992-10-07 1994-04-29 Warner Lambert Co Taste masking of thymol
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
US20020037855A1 (en) * 2000-05-05 2002-03-28 Fritz Stanislaus Stabilized medicament containing cysteinyl derivatives
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
FR2913338B1 (fr) * 2007-03-06 2009-07-24 Aditec Soc Par Actions Simplif Composition de rehydratation.

Also Published As

Publication number Publication date
EP2393516B1 (en) 2015-12-02
EP2393516A1 (en) 2011-12-14
WO2010090612A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
EA201001710A3 (ru) Фармацевтическая композиция, которая содержит соль стронция, витамин d и циклодекстрин
MX2011012504A (es) Pirazinilpirazoles.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
BR112012019997A2 (pt) composições de cuidado oral
IN2012DN02471A (tr)
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
TR200900881A2 (tr) Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
IN2012DN03096A (tr)